Invited Speaker Lancefield International Symposium for Streptococci and Streptococcal Diseases 2025

Progress towards licensure of a protein-based vaccine against Group B Streptococcus (123755)

Per Fischer 1
  1. MinervaX, Copenhagen, Denmark

Abstract details coming soon